ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,077,000 | +306.4% | 44,485 | +797.1% | 0.00% | +100.0% |
| Q4 2020 | $265,000 | -65.9% | 4,959 | -82.9% | 0.00% | -80.0% |
| Q1 2019 | $776,000 | +288.0% | 29,043 | +199.8% | 0.01% | +400.0% |
| Q3 2018 | $200,000 | -42.7% | 9,687 | -38.3% | 0.00% | -66.7% |
| Q1 2018 | $349,000 | -23.6% | 15,695 | -0.8% | 0.00% | -25.0% |
| Q4 2017 | $457,000 | +0.2% | 15,815 | +31.2% | 0.00% | 0.0% |
| Q3 2017 | $456,000 | +38.2% | 12,058 | +2.0% | 0.00% | +33.3% |
| Q2 2017 | $330,000 | -8.6% | 11,821 | +5.8% | 0.00% | 0.0% |
| Q1 2017 | $361,000 | +35.7% | 11,171 | +8.5% | 0.00% | 0.0% |
| Q4 2016 | $266,000 | +8.6% | 10,296 | +33.8% | 0.00% | 0.0% |
| Q3 2016 | $245,000 | +17.8% | 7,697 | +18.5% | 0.00% | 0.0% |
| Q2 2016 | $208,000 | -43.6% | 6,497 | -2.4% | 0.00% | +200.0% |
| Q1 2016 | $369,000 | +81.8% | 6,660 | +6.8% | 0.00% | -66.7% |
| Q1 2015 | $203,000 | – | 6,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |